Literature DB >> 24496993

[Mesothelial proliferation in rectal cancer].

P Adam1, C Schraml, B Sipos, F Fend.   

Abstract

In an epiphrenic lymph node of a 55 years old female patient who underwent surgical resection of a rectal adenocarcinoma epitheloid proliferations with papillary and solid growth pattern were seen additional to a metastasis of the carcinoma. Adjacent vessels contained similar infiltrates. Immunohistochemically a co-expression of pan-keratin, calretinin and WT1 was seen, suggestive for a diagnosis of a metastasis of a malignant mesothelioma. However, radiologic examination yielded no morphologic correlate to this suspicion. Further immunohistochemical work-up showed positivity for desmin, negativity for EMA, GLUT1, p53 and a low ki67-fraction of 2-3 %. Therefore, a final diagnosis of benign mesothelial proliferations disseminated into the lymph node and the adjacent vessels was made.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496993     DOI: 10.1007/s00292-013-1880-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  11 in total

1.  Hyperplastic mesothelial cells in mediastinal lymph node sinuses.

Authors:  D Suarez-Vilela; F M Izquierdo-Garcia
Journal:  Arch Pathol Lab Med       Date:  2000-12       Impact factor: 5.534

2.  Benign metastasizing mesothelial cells: a potential pitfall in mediastinal lymph nodes.

Authors:  Mufaddal T Moonim; Wen Wei Ng; Tom Routledge
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

3.  CD147 immunohistochemistry discriminates between reactive mesothelial cells and malignant mesothelioma.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; Tony R Soares; Helena Pereira; Carlos Bedrossian; Claire Michael; Fernando C Schmitt; Fátima Baltazar
Journal:  Diagn Cytopathol       Date:  2012-06       Impact factor: 1.582

4.  The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.

Authors:  Sara E Monaco; Yongli Shuai; Mona Bansal; Alyssa M Krasinskas; Sanja Dacic
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

5.  The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.

Authors:  Farnaz Hasteh; Grace Y Lin; Noel Weidner; Claire W Michael
Journal:  Cancer Cytopathol       Date:  2010-04-25       Impact factor: 5.284

6.  Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma.

Authors:  J S Brooks; V A LiVolsi; G G Pietra
Journal:  Am J Clin Pathol       Date:  1990-06       Impact factor: 2.493

7.  The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.

Authors:  R L Attanoos; A Griffin; A R Gibbs
Journal:  Histopathology       Date:  2003-09       Impact factor: 5.087

8.  Neoplastic and non-neoplastic mesothelial proliferations in pelvic lymph nodes.

Authors:  Y K Hsu; T H Parmley; N B Rosenshein; B S Bhagavan; J D Woodruff
Journal:  Obstet Gynecol       Date:  1980-01       Impact factor: 7.661

9.  IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations.

Authors:  Anna F Lee; Allen M Gown; Andrew Churg
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

10.  p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.

Authors:  F G Mayall; H Goddard; A R Gibbs
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.